PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'ReiThera Srl, Rome, Italy.\', \'School of Life Sciences, University of Nottingham, Nottingham, UK; NIHR Nottingham Biomedical Research Centre, University of Nottingham, Nottingham, UK; Wolfson Centre for Emerging Virus Research, University of Nottingham, Nottingham, UK.\', \'National Institute for Infectious Diseases \'Lazzaro Spallanzani\' IRCCS, Rome, Italy.\', \'ReiThera Srl, Rome, Italy. Electronic address: alessandra.vitelli@reithera.com.\']
?:citedBy
  • -1
?:creator
?:doi
  • S1525-0016(21)00210-010.1016/j.ymthe.2021.04.022
?:doi
?:hasPublicationType
?:journal
  • Molecular therapy : the journal of the American Society of Gene Therapy
is ?:pmid of
?:pmid
?:pmid
  • 33895322
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Immunogenicity of a new gorilla adenovirus vaccine candidate for COVID-19.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33895322>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33895322>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all